Previous 10 | Next 10 |
Bristol-Myers Receives FDA Approval for Celgene’s Ozanimod Bristol-Myers Squibb ( BMY ) (BMYMP) announced that it has received the FDA approval for Ozanimod, an MS drug it acquired through its purchase of Celgene business. The approval comes after quite a few roadblocks including ...
– Enhances Triferic platform by providing patients with greater access to Rockwell Medical’s innovative therapeutic by expanding administration options for clinicians – – Major milestone supports the potential for expanding global adoption of Triferic and trans...
MRAG Believes Recent Debt Financing Not in the Best Interest of Rockwell Shareholders MRAG Questions Business Judgment of Rockwell Directors and Management NEW YORK, March 25, 2020 (GLOBE NEWSWIRE) -- Medical Resource Acquisition Group, LLC (MRAG), an investment company focused...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Noteworthy events during the week of March 22 - 28 for healthcare investors (some could be canceled/postponed due to COVID-19). More news on: Bristol-Myers Squibb Company, Zogenix, Inc., Heron Therapeutics, Inc., Healthcare stocks news, , Read more ...
WIXOM, Mich., March 20, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“ Rockwell Medical ” or the “ Company ”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today re...
Amidst the deadly coronavirus outbreak, Wall Street suffered its biggest point drop in a single day on Monday and the Dow fell below 20,000 points at the end of Wednesday, nearly erasing all of the gains Trump has made during his presidency. Fed intervention has done little to stabilize marke...
NEW YORK, March 18, 2020 (GLOBE NEWSWIRE) -- Medical Resource Acquisition Group, LLC (MRAG), an investment company focused on facilitating the advancement of innovative healthcare companies, announces that it remains focused on replacing Rockwell Medical, Inc. (RMTI; NASDAQ) Directors Lisa ...
Rockwell Medical (NASDAQ: RMTI ) has entered into a debt financing agreement with an affiliate of Innovatus Capital Partners, LLC for up to $35M in term loans. More news on: Rockwell Medical, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
WIXOM, Mich., March 17, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced that it has entered into...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...